Narmac,

Of course, I've been watching BTI. It's been nice to see the share price head in the positive direction the past couple of weeks. Hopefully, our "prosperous new year" continues. It was also nice to see the Transcend/Trastuzumab (BT2111) paper get published. But we are all still waiting....hoping for a big announcement related to licensing deal(s) or their research program. A lot seems to be going on behind the scenes, but biOasis hasn't done much on the communication front lately.

I emailed Rob last week and asked if there are any conferences or events that biOasis is attending or presenting at in the remainder of Q3 or Q4. He responded just BIO-Europe, in November.

BearDownAZ